Eric Stanton Weiss

CIK: 0002009491

Transaction Breakdown

Open Market Buys (P)6 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CORZ

Core Scientific, Inc./tx

Director

NAKA

Kindly MD, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

CORZ
Core Scientific, Inc./tx
Sep 15, 2026
Purchase(P)
Direct
6K shares at avg. $16.33$98K
CORZ
Core Scientific, Inc./tx
Aug 18, 2026
Purchase(P)
Direct
7K shares at avg. $19.19$134K
CORZ
Core Scientific, Inc./tx
Mar 9, 2026
Purchase(P)
Direct
7K shares at avg. $14.53$102K
CORZ
Core Scientific, Inc./tx
Feb 4, 2026
Award(A)
Direct
18.6K shares-
CORZ
Core Scientific, Inc./tx
Nov 4, 2025
Purchase(P)
Direct
5K shares at avg. $21.50$108K
NAKA
Kindly MD, Inc.
Sep 22, 2025
Award(A)
Direct
112.8K shares-
CORZ
Core Scientific, Inc./tx
Mar 6, 2025
Purchase(P)
Direct
6K shares at avg. $8.46$51K
CORZ
Core Scientific, Inc./tx
Jan 27, 2025
Award(A)
Direct
20.4K shares-
CORZ
Core Scientific, Inc./tx
Sep 9, 2024
Purchase(P)
Direct
5K shares at avg. $9.21$46K

		Type	Shares	Price		Ownership
Sep 15, 2026	CORZ Core Scientific, Inc./tx	Purchase(P)	6,000	$16.33	$97,980	Direct
Aug 18, 2026	CORZ Core Scientific, Inc./tx	Purchase(P)	7,000	$19.19	$134,358	Direct
Mar 9, 2026	CORZ Core Scientific, Inc./tx	Purchase(P)	7,000	$14.53	$101,700	Direct
Feb 4, 2026	CORZ Core Scientific, Inc./tx	Award(A)	18,575	-	$0	Direct
Nov 4, 2025	CORZ Core Scientific, Inc./tx	Purchase(P)	5,000	$21.50	$107,500	Direct
Sep 22, 2025	NAKA Kindly MD, Inc.	Award(A)	112,781	-	-	Direct
Mar 6, 2025	CORZ Core Scientific, Inc./tx	Purchase(P)	6,000	$8.46	$50,750	Direct
Jan 27, 2025	CORZ Core Scientific, Inc./tx	Award(A)	20,448	-	$0	Direct
Sep 9, 2024	CORZ Core Scientific, Inc./tx	Purchase(P)	5,000	$9.21	$46,050	Direct

1-9 of 9 transactions

About Weiss Eric Stanton

Weiss Eric Stanton (SEC CIK 0002009491) files insider reports with the SEC as Director of Core Scientific, Inc./tx (CORZ) and Director of Kindly MD, Inc. (NAKA).

Signal8 holds 10 ownership filings by Weiss Eric Stanton (1 Form 3, 9 Form 4), filed between Sep 10, 2024 and Sep 17, 2026. Those filings report 9 transactions, from Sep 9, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Weiss Eric Stanton's filings is in DOVER, DE.

Recent filings by Weiss Eric Stanton

Sep 15, 2026: Open-market purchase of CORZ shares (Form 4, code P).
Aug 18, 2026: Open-market purchase of CORZ shares (Form 4, code P).
Mar 9, 2026: Open-market purchase of CORZ shares (Form 4, code P).
Feb 4, 2026: Grant or award of CORZ shares (Form 4, code A).
Nov 4, 2025: Open-market purchase of CORZ shares (Form 4, code P).

Other insiders filing for Core Scientific, Inc./tx (CORZ)

DUCHENE TODD M
Sullivan Adam Taylor, Chief Executive Officer
CRAIN ELIZABETH, Director
Adams Mark, Director
Smith Stephen M, Director
Nygaard James P Jr, EVP, Chief Financial Officer

How to read Form 4 transaction codes